Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Discover startups that we recently backed. We've checked the details of each description at time of writing, though these may change. Please enjoy as general information only.
Our fund is open for investment. For more information see here or if you have questions then please get in touch.
Access EIS invested in Haboo MoneyHaboo Money operates a loan repayment platform using open banking that supports both lenders and borrowers.
Access EIS invested in H2ChpH2Chp develops co-generation technology which produces heat and power from fuel with an aim of making electricity generation and distribution more efficient.
Access EIS invested in KymiraKymira uses cutting-edge nano and microelectronic production techniques to develop thermo-reactive clothing that's used across medical, sport, space, and defence.
Access EIS invested in TheovacoOva provides supplements to support egg health, fertility, IVF and pregnancy.
Access EIS invested in MindspireMindspire provides a range of services to help users reduce stress using a range of data science techniques.
Access EIS invested in Zeus SleepZeus is a revolutionary, non-invasive snoring solution developed in collaboration with King's College London and Guy's & St Thomas' NHS Foundation Trust. This discreet, lightweight device uses gentle TENS technology to stimulate the tongue muscles and keep airways open, helping users sleep deeper, quieter, and more peacefully.
Access EIS invested in AnyaWinner of the National AI Awards for Healthcare in 2024, Anya is a digital health solution that combines pioneering AI technology with the expertise of human healthcare specialists to offer personalised 24/7 support for women's health from fertility through pregnancy to parenthood and menopause.
Access EIS invested in Good & Proper TeaGood & Proper Tea is on a mission to show the world how good tea can be. It's a speciality tea supplier based in London and offers a wide variety of premium quality, award-winning loose leaf teas, tea bags and tea accessories.
Access EIS invested in LeafrLeafr operates an online recruitment platform which aims to connect clients with vetted freelance sustainability consultants. The business was founded to address a problem faced by a growing number of businesses attempting to operate sustainably: that it is a struggle to find quality sustainability talent.
Access EIS invested in Days BrewingDays is a brewer specialising in non-alcoholic beer. In January 2025, The Grocer reported that Days had become the fastest-growing low and no-alcohol brand in retail, after its retail sales grew by 160% in one year, a value of at least £250k.
Access EIS invested in London DevicesLondon Devices makes SmartGauge, an orthopaedic device to make trauma surgery safer, quicker and less costly.
Access EIS invested in FinCrime DynamicsFinCrime Dynamics helps clients build better defences against financial crime by translating financial crime intelligence into data resources using its simulation and synthetic data engine, Synthetizor.
Access EIS invested in PocklaPockla is an AI platform that helps marketeers ideate content that captures the attention of audiences. It works to connect everyday events with audience emotions and assist creators in developing content that speaks to their audience, increasing engagement and reach while reducing time spent prompting AI.
Access EIS invested in BOWBOW develops apps and software which aim to make programming robotics more simple, lowering the barrier of entry to new users. BOW's product enables users to create and test code using popular programming languages and deploy it for use by one of BOW's supported robots, overcoming obstacles like impenetratable manufacturer APIs that date quickly and a lack of standardisation.
Access EIS invested in Wilder SensingWilder Sensing develops a biodiversity monitoring and reporting AI platform to help address declining biodiversity. It offers users long and short term surveys, environmental impact assessment analysis, site restoration, site management and ongoing monitoring services.
Access EIS invested in ManholeMetricsManholeMetrics develops sensors for monitoring wastewater and provides analytics and alerts for flood management and prevention. Its mission is to bring wastewater mangement into the 21st century, with a sensor-driven approach enabling proactive measures to be taken to address blockages, collapses and flooding.
Access EIS invested in Material IndexMaterial Index provides a digital platform for building owners and contractors to manage and exchange materials and enable their reuse. More than 60% of the UK's waste is generated by the construction industry, with only 2% of building components seeing reuse. Material Index specialises in brokering the onward trade of materials arising from the deconstuction, refurbishment and demolition of buildings, while offering auditing services to assess projects' potential for reuseable materials.
Access EIS invested in ColliderCollider develops and sells non-alcoholic beer infused with adaptogens, nootropics and functional mushrooms, to provide a mood-boosting alternative to alcohol. Its beer is made using traditional ingredients and brewed in exactly the same way as alcoholic beer, but uses special strains of yeast and environmental control to ensure its alcohol content never goes above 0.5%. It's then infused with adaptopgens using a technique that ensures the flavour isn't impacted. Collider secured a raise of £720k in pre-seed funding in October, exceeding its target of 600k. It has seen very encouraging early sales, selling out six months' worth of product in just two months.
Access EIS invested in CliqCLIQ is a social networking platform that connects communities online and offline, with a mission to address social isolation and allow people to easily form meaningful connections. CLIQ allows users to interact and connect with like-minded individuals and join interest-based clubs and in-person communities.
Access EIS invested in ReomeREOME supplies a range of skincare products that harness the power of advanced biotechnology and biofermentation, representing a new revolution in science-led skincare. Biotechnology has been shown to offer a level of visible results never before seen in skincare products. The ingredients cultuaved through biotechnology have a molecular structure similar to the skin itself, which allows for more skin compatibility, greater absorption, and better results. Founded by multi-award-winning beauty journalist and brand consultant Joanna Ellner, REOME's approach engages the latest biotechnology processes to creative products that place efficacy at the heart of the brand and actively boost skin health, restore hydration and enhance radiance.